Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.525
-0.045 (-2.87%)
May 18, 2026, 10:28 AM EDT - Market open
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $235.23 million as of May 18, 2026. Its market cap has increased by 93.29% in one year.
Market Cap
235.23M
Enterprise Value
129.50M
1-Year Change
93.29%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $235.23M, a decrease of -41.80%. That is a compound annual growth rate of -4.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 242.20M | 41.14% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 256.51M |
| Tonix Pharmaceuticals Holding | 250.91M |
| Artiva Biotherapeutics | 241.73M |
| Alector | 239.81M |
| Sol-Gel Technologies | 237.72M |
| Cybin | 233.67M |
| Whitehawk Therapeutics | 232.31M |
| Adagene | 231.25M |